Arndt Schottelius

Company: Affimed

Job title: CSO

Seminars:

Clinical Data Update: Marking Progress in Liquid & Solid Tumor Development with Engager & Adoptive NK Combination Therapies 9:40 am

Sharing pharmacodynamics and pharmacokinetics updates from dose escalation trials with EGFR-targeted bispecific NK cell engagers in solid tumors Marking development in bispecific engager combinations with PD-L1 and adoptive NK therapies Discussing future product design concepts with co-vialed, cryopreserved, off-the-shelf combination approaches to drive accessibility of combination cell therapiesRead more

day: Day Two